Global pharmaceutical giant Glaxosmithkline has received a £1.46 million research and development grant in Scotland.
The Scottish Enterprise money will be used to position GSK's Montrose plant as a new product development facility and could lead to 25 jobs being created.
Andy Ross, site director, said: "We are very grateful to Scottish Enterprise for all their efforts in relation to the R&D grant.
"Their financial support will allow us toprovide the right people, plant and expertise at a critical time for the GSK Montrose site as we look to introduce innovative new processes so as to maintain our global cost effectiveness.
"This forms a key part of our future development and sustainability."
Linda Hanna, director of company growth at Scottish Enterprise, said: "In the current economic conditions, it's critical that more companies continue to innovate so that the Scottish economy maintains its competitive edge.
"This R&D grant will allow Glaxosmithkline to do just that, by increasing efficiencies and introducing new products to its Montrose site.
"Grant support is an integral part of the overall support from Scottish Enterprise to the company through our account management approach.
"By working closely with the management team, we have developed a mutual understanding of how we can focus our help to assist them to achieve their global growth objectives through increased investment and commitment to their operations in Scotland."